Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yonghao Yang

Factors Influencing the Efficacy of Anti-Pd-1 Therapy in Chinese Patients With Advanced Melanoma

Journal of Oncology

Oncology

2019

English

Use of Basalt Fiber-Reinforced Tailings for Improving the Stability of Tailings Dam

Materials

Materials Science

Condensed Matter Physics

2019

English

Related publications

Ineffective Anti PD-1 Therapy After BRAF Inhibitor Failure in Advanced Melanoma

English

Comment on ‘Efficacy and Toxicity of Treatment With the Anti-Ctla-4 Antibody Ipilimumab in Patients With Metastatic Melanoma After Prior Anti-Pd-1 Therapy’

British Journal of Cancer

Cancer Research

Oncology

2017

English

Site‐specific Response Patterns, Pseudoprogression, and Acquired Resistance in Patients With Melanoma Treated With Ipilimumab Combined With Anti–PD‐1 Therapy

English

Cutaneous Adverse Events (AEs) of Anti-Programmed Cell Death (PD)-1 Therapy in Patients With Metastatic Melanoma: A Single-Institution Cohort

Journal of the American Academy of Dermatology

Dermatology

2016

English

Safety and Tumor Responses With Lambrolizumab (Anti–PD-1) in Melanoma

New England Journal of Medicine

Medicine

2013

English

OA05.01 Efficacy/Safety of Entinostat (ENT) and Pembrolizumab (PEMBRO) in NSCLC Patients Previously Treated With Anti-Pd-(L)1 Therapy

Journal of Thoracic Oncology

English

P104 Anti-Pd-1 Combination Therapy in Second or Later Lines in Patients With Advanced Non Small Cell Lung Cancer

Journal of Thoracic Oncology

English

P3.04-21 Antibiotics Attenuate the Clinical Benefit of Anti-Pd-(L)1 Immunotherapies in Chinese Patients With Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

Comprehensive Molecular and Clinical Characterization of Asian Melanoma Patients Treated With Anti-Pd-1 Antibody

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yonghao Yang

Factors Influencing the Efficacy of Anti-Pd-1 Therapy in Chinese Patients With Advanced Melanoma

Use of Basalt Fiber-Reinforced Tailings for Improving the Stability of Tailings Dam

Related publications

Ineffective Anti PD-1 Therapy After BRAF Inhibitor Failure in Advanced Melanoma

Comment on ‘Efficacy and Toxicity of Treatment With the Anti-Ctla-4 Antibody Ipilimumab in Patients With Metastatic Melanoma After Prior Anti-Pd-1 Therapy’

Site‐specific Response Patterns, Pseudoprogression, and Acquired Resistance in Patients With Melanoma Treated With Ipilimumab Combined With Anti–PD‐1 Therapy

Cutaneous Adverse Events (AEs) of Anti-Programmed Cell Death (PD)-1 Therapy in Patients With Metastatic Melanoma: A Single-Institution Cohort

Safety and Tumor Responses With Lambrolizumab (Anti–PD-1) in Melanoma

OA05.01 Efficacy/Safety of Entinostat (ENT) and Pembrolizumab (PEMBRO) in NSCLC Patients Previously Treated With Anti-Pd-(L)1 Therapy

P104 Anti-Pd-1 Combination Therapy in Second or Later Lines in Patients With Advanced Non Small Cell Lung Cancer

P3.04-21 Antibiotics Attenuate the Clinical Benefit of Anti-Pd-(L)1 Immunotherapies in Chinese Patients With Advanced Non-Small Cell Lung Cancer

Comprehensive Molecular and Clinical Characterization of Asian Melanoma Patients Treated With Anti-Pd-1 Antibody